Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
Ontologies
Phenotypes
Genetic Variation
- Variant table
- Variant image
- Structural variants
Gene expression
Pathway
Molecular interactions
Regulation
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: ITGAX ENSCJAG00000003169

.

Description

integrin subunit alpha X [Source:NCBI gene (formerly Entrezgene);Acc:100396593]

Gene Synonyms

CD11c

Location

Primary_assembly 12: 28,489,116-28,685,691 forward strand.

mCalJac1.pat.X:CM021926.1

About this gene

This gene has 6 transcripts (splice variants), 269 orthologues and 15 paralogues.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	UniProt Match	Flags
ENSCJAT00000135219.1	ITGAX-206	3569	1166aa	ENSCJAP00000081859.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A8I3VYM7	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical,
ENSCJAT00000006203.5	ITGAX-205	3621	1161aa	ENSCJAP00000005891.4	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A6N6I7	-
ENSCJAT00000099999.2	ITGAX-203	2872	538aa	ENSCJAP00000076803.2	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A5F4WGI4	-
ENSCJAT00000006124.5	ITGAX-201	2588	503aa	ENSCJAP00000005816.5	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A8J8XZ89	-
ENSCJAT00000102264.2	ITGAX-202	2106	562aa	ENSCJAP00000071853.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A5F4W203	-
ENSCJAT00000006108.3	ITGAX-204	1674	503aa	ENSCJAP00000005800.2	Gene/transcipt that contains an open reading frame (ORF).Protein coding	F7HVQ2	-

.

Summary

.

.